|
Sign In to gain access to subscriptions and/or personal tools.
|
Interactions between apelin and angiotensin II on rat portal vein
Bogdan Gurzu
Faculty of Medicine, Department of Physiology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania, bgurzu@ yahoo.com, Faculty of Medicine, Department of Ophthalmology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania
Bogdan Cristian Petrescu
Faculty of Bioengineering, Department of Ophthalmology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania
Marcel Costuleanu
Faculty of Dentistry, Department of General Pathology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania
Gheorghe Petrescu
Faculty of Medicine, Department of Physiology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania, Department of Ophthalmology, University of Medicine and Pharmacy "Gr. T Popa" Iasi, Romania
Apelin (AP), an endogenous ligand of the APJ receptor, is involved in the regulation of cardiovascular homeostasis. Regardless the multiple similarities between AP and angiotensin II (Ang II), their roles seem to be different. We studied both the interactions between Apelin 13 (AP13) and Ang II and to what extent, if any, nitric oxide (NO) is involved.The experiments were performed in endothelium-denuded or endothelium-intact rat portal vein in the presence of 10 µM N(G)-nitro L-arginine methyl ester or 10 µM aminoguanidine. AP13 did not modify the isolated rat portal vein tone by itself, but inhibited the Ang II-induced contractions acting mainly by a NO-dependent mechanism. Our results sustain the hypothesis that AP13 could increase the activity of both constitutive and inducible NO synthase on either endothelium intact or endothelium denuded rat portal vein rings.
Key Words: apelin angiotensin II L-NAME aminoguanidine isolated rat portal vein
References
- Tatemoto K., Hosoya M., Habata Y. et al. Isolation and characterization of a novel en-dogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251:471-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- O'Dowd BF, Heiber M., Chan A. et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136:355-60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Falco M., De Luca L., Onori N. et al. Apelin expression in normal human tissues. In Vivo 2002;16:333-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Vickers C., Hales P., Kaushik V. et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002;277:14838-43.[Abstract/Free Full Text]
- Kleinz MJ, Davenport AP Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004;118:119-25.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chen MM, Ashley EA, Deng DX et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003;108:1432-9.[Abstract/Free Full Text]
- Tatemoto K., Takayama K., Zou MX et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001;99(2-3):87-92.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 2001;132:1255-60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Foldes G., Horkay F., Szokodi I. et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003;308:480-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Szokodi I., Tavi P., Foldes G. et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002;91:434-40.[Abstract/Free Full Text]
- Taheri S., Murphy K., Cohen M. et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002;291:1208-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lee DK, Cheng R., Nguyen T. et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74(1):34-41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Iwanaga Y., Kihara Y., Takenaka H., Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 re-ceptor system. J Mol Cell Cardiol 2006;41:798-806.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gurzu B., Costuleanu M., Slatineanu SM, Ciobanu A., Petrescu G. Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein? JRAAS 2005;6:90-5.[Medline]
[Order article via Infotrieve]
- Zhang JS, Van Meel JC, Pfaffendorf M., Van Zwieten PA Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve. J Pharmacol Exp Ther 1994;269:509-14.[Abstract/Free Full Text]
- Kwok YG, Moore GJ Comparison of angiotensin receptors in isolated smooth muscle tissues by photoaffinity labelling. Eur J Pharmacol 1985;115(1):53-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scanlon MN, Moore GJ Classification of Tangiotensin receptors in rat isolated uterus, portal vein, and aorta using a slowly dissociating antagonist [Sar1,Ile8]ANG II for receptor blockade. J Pharmacol Methods 1988;20:207-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pelet C., Mironneau C., Rakotoarisoa L., Neuilly G. Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle. Eur J Pharmacol 1995;279(1):1524.
- Zhang JS, Van Meel JC, Pfaffendorf M., Van Zwieten PA Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein. Naunyn Schmiedebergs Arch Pharmacol 1993;347:220-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cheng X., Cheng XS, Pang CC Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 2003;470:171-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ishida J., Hashimoto T., Hashimoto Y. et al. Regulatory roles for APJ, a seven-transmembrane receptor related to AT1, in blood pressure in vivo. J Biol Chem 2004;279:26274-9.[Abstract/Free Full Text]
- Buchwalow IB, Podzuweit T., Bocker W. et al. Vascular smooth muscle and nitric oxide synthase. FASEB J 2002;16:500-08.[Abstract/Free Full Text]
- Buchwalow IB, Podzuweit T., Samoilova VE et al. An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide 2004;10:203-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Degnim AC, Nakayama DK Nitric oxide and the pulmonary artery smooth muscle cell. Semin Pediatr Surg 1996; 5:160-4.[Medline]
[Order article via Infotrieve]
- Schini VB, Vanhoutte PM Nitric oxide and homeostasis of the smooth vascular muscle. Arch Mal Coeur Vaiss 1993; 86(Spec No 1):83-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Schini-Kerth VB Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis. Transfus Clin Biol 1999;6:355-63.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Datte JY, Offoumou MA Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle. J Pharm Pharm Sci 2004;7(1):1-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Eder V., Gautier M., Boissiere J., Girardin C., Rebocho M., Bonnet P. Gamma irradiation induces acetylcholine-evoked, endothelium-independent relaxation and activates K-channels of isolated pulmonary artery of rats. Int J Radiat Oncol Biol Phys 2004;60:1530-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Griffiths MJ, Messent M., Curzen NP, Evans TW Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am J Respir Crit Care Med 1995;152:1599-604.[Abstract]
- Scott JA, Machoun M., McCormack DG Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. J Appl Physiol 1996;80:271-7.[Abstract/Free Full Text]
- Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide syn-thase isoforms. Biochem Pharmacol 1996;51:383-94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 4,
212-216 (2006)
DOI: 10.3317/jraas.2006.040

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Chandrasekaran, O. Dar, and T. McDonagh
The role of apelin in cardiovascular function and heart failure
Eur J Heart Fail,
August 1, 2008;
10(8):
725 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|